Functional Fluidics
Detroit, US · Delaware corporation · 6 known investors
Functional Fluidics develops diagnostic tools to objectively monitor red blood cell health in patients with Sickle Cell Disease. The company creates biomarkers for healthcare providers, patients, and pharmaceutical companies to improve disease monitoring and treatment response assessment.
Founders & leadership
JC
John CunninghamChief Operating Officer
PH
Patrick HinesCEO & Founder
Investors · 6
Reported raises · per SEC filings
Form D private placements▶$3.4MraisedJan 2021 · 22 investors · Other Health CareRule 506(b)
▶$3.4MraisedJan 2021 · 22 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Patrick HinesExecutive Officer, Director
- Offering amount
- $3.5M
- Amount sold
- $3.4M
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$150KraisedMay 2019 · 1 investors · Other Health CareRule 506(b)
▶$150KraisedMay 2019 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John CunninghamExecutive Officer
- Patrick HinesExecutive Officer
- Offering amount
- $2M
- Amount sold
- $150K
- First sale
- Apr 2019
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.